Search for: "Janssen Research " Results 121 - 140 of 200
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Dec 2015, 11:50 am by Brenda Fulmer
   Xarelto was developed by German pharmaceutical giant Bayer, and is jointly marketed in the United States with Janssen Pharmaceuticals, a division of Johnson & Johnson. [read post]
12 Mar 2021, 11:57 am by Lonnie Roach
There are now three vaccines available: Pfizer-BioNTech, Moderna, and Johnson & Johnson/Janssen. [read post]
30 May 2017, 5:17 am by Howard Knopf
Janssen-Ortho Inc., 2009 FCA 212 (CanLII), where the need for explicit “acknowledgment” of the adoption of a party’s written submissions was addressed. [read post]
6 Dec 2021, 6:24 am by Lisa Larrimore Ouellette
Phase 2/3 clinical trials began in February 2021 for Pfizer/BioNTech and Janssen and included pregnant people. [read post]
30 May 2017, 5:17 am by Howard Knopf
Janssen-Ortho Inc., 2009 FCA 212 (CanLII), where the need for explicit “acknowledgment” of the adoption of a party’s written submissions was addressed. [read post]
22 Oct 2021, 11:36 am by Pamela Wolf
They argued that Johnson & Johnson/Janssen used cells ultimately derived from an aborted fetus to produce its vaccine, as did Moderna and Pfizer/BioNTech in researching their vaccines. [read post]
18 Oct 2014, 1:09 pm by Dr. Shezad Malik
Researchers found that over half of patients experienced symptoms lasting more than a year, and 80% characterized the nerve problems as severe. [read post]
22 Dec 2015, 7:03 am by Dr. Shezad Malik
Xarelto was developed and sold jointly by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary and Bayer Healthcare. [read post]
11 Jan 2011, 11:07 pm by Kelly
Supreme Court to take on patent settlement agreements: Louisiana Wholesale Drug Co et al v Bayer et al (FDA Law Blog) US: BIO joins 170 business, research institutions and organisations to urge caution in Microsoft v i4i case (PatentlyBIOtech) US: Galderma wins important victory in fight against Leo’s psoriasis patent covering vitamin D, corticosteroid composition for ‘dermal use’ (Reexamination Alert) US: Déjà vu! [read post]
20 Oct 2019, 7:35 pm by Jean O'Grady
You will also have the opportunity to see a sophisticated new approach to AI enabled legal research. [read post]
24 Dec 2015, 6:43 am by Dr. Shezad Malik
Xarelto was developed and sold jointly by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary and Bayer Healthcare. [read post]
29 Sep 2020, 5:52 am by MaxVal
At MaxVal, our expert searchers/domain experts conduct unrestricted patent research using the latest tools and best practices developed over more than fifteen years. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/8: Alza Corporation and Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
29 Apr 2016, 11:51 am by highrank
Zofran Used for suppressing nausea, some research has linked this to birth defects in pregnant women. [read post]
21 Apr 2017, 6:25 am
Bulan, Cornerstone Research, on Tuesday, April 18, 2017 Tags: Accounting, Class actions, Derivative suits, Disclosure, Institutional Investors, Market reaction, Rule 10b-5, SEC, SEC enforcement, Section 11, Securities damages, Securities enforcement, Securities litigation, Securities regulation, Settlements Sustainability Matters: Focusing on your Future Today Posted by Elisse B. [read post]
22 Oct 2021, 11:36 am by Pamela Wolf
They argued that Johnson & Johnson/Janssen used cells ultimately derived from an aborted fetus to produce its vaccine, as did Moderna and Pfizer/BioNTech in researching their vaccines. [read post]